178 related articles for article (PubMed ID: 31931095)
1. Sanguinarine as a new chemical entity of thioredoxin reductase inhibitor to elicit oxidative stress and promote tumor cell apoptosis.
Yao J; Duan D; Song ZL; Zhang J; Fang J
Free Radic Biol Med; 2020 May; 152():659-667. PubMed ID: 31931095
[TBL] [Abstract][Full Text] [Related]
2. Revealing PACMA 31 as a new chemical type TrxR inhibitor to promote cancer cell apoptosis.
Xu Q; Zhang J; Zhao Z; Chu Y; Fang J
Biochim Biophys Acta Mol Cell Res; 2022 Oct; 1869(10):119323. PubMed ID: 35793738
[TBL] [Abstract][Full Text] [Related]
3. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase.
Zhang J; Yao J; Peng S; Li X; Fang J
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):129-138. PubMed ID: 27777067
[TBL] [Abstract][Full Text] [Related]
4. Oridonin Induces Oxidative Stress-mediated Cancer Cells Apoptosis
Duan D; Feng X; Pan D; Wang L; Wang Y; Wang X
Curr Pharm Biotechnol; 2022; 23(14):1647-1657. PubMed ID: 34923938
[TBL] [Abstract][Full Text] [Related]
5. The thioredoxin system and cancer therapy: a review.
Mohammadi F; Soltani A; Ghahremanloo A; Javid H; Hashemy SI
Cancer Chemother Pharmacol; 2019 Nov; 84(5):925-935. PubMed ID: 31367788
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells.
Zhang J; Li Y; Duan D; Yao J; Gao K; Fang J
Biochem Pharmacol; 2016 Feb; 102():34-44. PubMed ID: 26686580
[TBL] [Abstract][Full Text] [Related]
7. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
9. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
Huang J; Xu J; Tian L; Zhong L
Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
[TBL] [Abstract][Full Text] [Related]
10. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
Montano SJ; Lu J; Gustafsson TN; Holmgren A
Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thioredoxin reductase by natural anticancer candidate β-lapachone accounts for triggering redox activation-mediated HL-60 cell apoptosis.
Zhang J; Xu Q; Ma D
Free Radic Biol Med; 2022 Feb; 180():244-252. PubMed ID: 35091063
[TBL] [Abstract][Full Text] [Related]
12. Potential Anticancer Activity of Auranofin.
Onodera T; Momose I; Kawada M
Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
Fang J; Holmgren A
J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
[TBL] [Abstract][Full Text] [Related]
14. Onopordopicrin from the new genus
Zhang J; Zheng ZQ; Xu Q; Li Y; Gao K; Fang J
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):790-801. PubMed ID: 33733960
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin reductase as a pharmacological target.
Bjørklund G; Zou L; Wang J; Chasapis CT; Peana M
Pharmacol Res; 2021 Dec; 174():105854. PubMed ID: 34455077
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Thioredoxin System for Cancer Therapy.
Zhang J; Li X; Han X; Liu R; Fang J
Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin system in cell death progression.
Lu J; Holmgren A
Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
[TBL] [Abstract][Full Text] [Related]
18. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A
J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex.
Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K
J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
